Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glycocalyx | 13 | 2023 | 89 | 4.940 |
Why?
|
Heparitin Sulfate | 16 | 2023 | 225 | 4.280 |
Why?
|
Lung Injury | 10 | 2023 | 432 | 3.740 |
Why?
|
Glycosaminoglycans | 8 | 2023 | 624 | 2.970 |
Why?
|
Sepsis | 18 | 2024 | 2593 | 2.770 |
Why?
|
Endothelium | 5 | 2019 | 777 | 1.790 |
Why?
|
Lung | 23 | 2023 | 9858 | 1.530 |
Why?
|
Lymphoma, Mantle-Cell | 2 | 2023 | 233 | 1.490 |
Why?
|
Acute Lung Injury | 7 | 2022 | 380 | 1.490 |
Why?
|
Respiratory Insufficiency | 5 | 2023 | 1199 | 1.010 |
Why?
|
Endotoxemia | 2 | 2018 | 207 | 0.970 |
Why?
|
Endothelium, Vascular | 6 | 2019 | 4459 | 0.920 |
Why?
|
Pneumonia, Bacterial | 2 | 2023 | 316 | 0.890 |
Why?
|
Oligosaccharides | 4 | 2023 | 415 | 0.850 |
Why?
|
Pneumonia | 5 | 2022 | 2133 | 0.820 |
Why?
|
Silver Staining | 1 | 2021 | 64 | 0.790 |
Why?
|
Glucuronidase | 5 | 2020 | 207 | 0.770 |
Why?
|
Fluid Therapy | 3 | 2019 | 593 | 0.760 |
Why?
|
Pulmonary Atelectasis | 1 | 2022 | 145 | 0.760 |
Why?
|
Heparan Sulfate Proteoglycans | 1 | 2021 | 118 | 0.750 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 687 | 0.710 |
Why?
|
Neutrophils | 5 | 2017 | 3718 | 0.700 |
Why?
|
Critical Illness | 4 | 2022 | 2670 | 0.680 |
Why?
|
Sulfotransferases | 1 | 2019 | 151 | 0.660 |
Why?
|
Heparin | 4 | 2020 | 1637 | 0.650 |
Why?
|
Endothelial Cells | 6 | 2021 | 3482 | 0.650 |
Why?
|
Interleukin-18 | 1 | 2020 | 249 | 0.640 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2021 | 1800 | 0.640 |
Why?
|
Blood Coagulation Disorders | 1 | 2020 | 337 | 0.590 |
Why?
|
Bleomycin | 3 | 2020 | 512 | 0.570 |
Why?
|
Shock | 1 | 2018 | 318 | 0.550 |
Why?
|
Cell Communication | 3 | 2017 | 1621 | 0.530 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2017 | 599 | 0.500 |
Why?
|
Animals | 42 | 2024 | 168660 | 0.460 |
Why?
|
Capillary Permeability | 3 | 2018 | 798 | 0.460 |
Why?
|
Mice | 26 | 2024 | 81154 | 0.450 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 815 | 0.430 |
Why?
|
Ephrin-A1 | 1 | 2012 | 9 | 0.420 |
Why?
|
Chondroitin Sulfates | 4 | 2023 | 187 | 0.420 |
Why?
|
Receptor, EphA2 | 1 | 2012 | 42 | 0.410 |
Why?
|
Gap Junctions | 1 | 2013 | 233 | 0.410 |
Why?
|
Memory Disorders | 1 | 2019 | 1186 | 0.400 |
Why?
|
Cell-Derived Microparticles | 1 | 2013 | 168 | 0.400 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2012 | 122 | 0.400 |
Why?
|
Influenza, Human | 1 | 2022 | 1480 | 0.390 |
Why?
|
Acute Kidney Injury | 4 | 2019 | 1968 | 0.360 |
Why?
|
Cell Adhesion Molecules | 1 | 2016 | 1602 | 0.350 |
Why?
|
Hippocampus | 2 | 2019 | 3672 | 0.350 |
Why?
|
Shock, Septic | 1 | 2016 | 775 | 0.350 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 2 | 1 | 2008 | 2 | 0.340 |
Why?
|
Virulence | 2 | 2023 | 1328 | 0.330 |
Why?
|
Hyperoxia | 1 | 2011 | 262 | 0.330 |
Why?
|
Fellowships and Scholarships | 3 | 2021 | 1077 | 0.310 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1120 | 0.310 |
Why?
|
Antiviral Agents | 1 | 2020 | 2984 | 0.310 |
Why?
|
Guanylate Cyclase | 1 | 2008 | 201 | 0.310 |
Why?
|
Hyperalgesia | 1 | 2012 | 502 | 0.310 |
Why?
|
Syndecan-1 | 4 | 2023 | 165 | 0.300 |
Why?
|
Histones | 1 | 2017 | 2598 | 0.300 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1962 | 0.290 |
Why?
|
Lipopolysaccharides | 4 | 2019 | 2217 | 0.280 |
Why?
|
Endotoxins | 3 | 2020 | 527 | 0.270 |
Why?
|
Resuscitation | 3 | 2019 | 658 | 0.270 |
Why?
|
Colorado | 2 | 2016 | 163 | 0.270 |
Why?
|
Humans | 50 | 2024 | 743811 | 0.260 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1534 | 0.260 |
Why?
|
Respiratory Function Tests | 3 | 2020 | 1615 | 0.250 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2014 | 2110 | 0.250 |
Why?
|
Anticoagulants | 1 | 2020 | 4599 | 0.250 |
Why?
|
Inflammation | 6 | 2022 | 10629 | 0.250 |
Why?
|
Tissue Plasminogen Activator | 2 | 2021 | 1263 | 0.230 |
Why?
|
Pulmonary Alveoli | 2 | 2020 | 674 | 0.230 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2401 | 0.230 |
Why?
|
Gene Expression Regulation | 2 | 2020 | 12066 | 0.230 |
Why?
|
Hospital Mortality | 2 | 2017 | 5316 | 0.230 |
Why?
|
Staphylococcal Infections | 2 | 2024 | 1400 | 0.210 |
Why?
|
Rodentia | 1 | 2024 | 261 | 0.210 |
Why?
|
Mice, Inbred C57BL | 11 | 2020 | 21824 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3134 | 0.210 |
Why?
|
Cytotoxins | 1 | 2022 | 153 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3241 | 0.210 |
Why?
|
Ion Exchange | 1 | 2021 | 16 | 0.200 |
Why?
|
Cell Adhesion | 3 | 2013 | 3144 | 0.200 |
Why?
|
Disease Models, Animal | 9 | 2023 | 18027 | 0.200 |
Why?
|
Desiccation | 1 | 2021 | 71 | 0.190 |
Why?
|
Calcitonin | 1 | 2022 | 336 | 0.190 |
Why?
|
Signal Transduction | 4 | 2020 | 23398 | 0.190 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2203 | 0.190 |
Why?
|
Respiration, Artificial | 2 | 2022 | 2568 | 0.180 |
Why?
|
Solutions | 1 | 2021 | 426 | 0.180 |
Why?
|
Pneumococcal Infections | 1 | 2004 | 497 | 0.180 |
Why?
|
Atherosclerosis | 1 | 2016 | 3445 | 0.180 |
Why?
|
Mice, Knockout | 6 | 2022 | 14563 | 0.170 |
Why?
|
Male | 23 | 2023 | 349776 | 0.170 |
Why?
|
Pulmonary Medicine | 1 | 2021 | 213 | 0.170 |
Why?
|
Blood Specimen Collection | 1 | 2020 | 246 | 0.170 |
Why?
|
Thrombomodulin | 1 | 2019 | 102 | 0.170 |
Why?
|
Syndecans | 1 | 2018 | 79 | 0.170 |
Why?
|
Apoptosis | 2 | 2014 | 9718 | 0.160 |
Why?
|
Research Report | 1 | 2022 | 355 | 0.160 |
Why?
|
Angiopoietin-2 | 1 | 2019 | 172 | 0.160 |
Why?
|
Patient Positioning | 1 | 2021 | 324 | 0.160 |
Why?
|
Brain-Derived Neurotrophic Factor | 2 | 2019 | 604 | 0.160 |
Why?
|
Protein Precursors | 1 | 2022 | 1154 | 0.160 |
Why?
|
Atrial Natriuretic Factor | 1 | 2019 | 393 | 0.160 |
Why?
|
Diagnosis, Differential | 2 | 2023 | 12954 | 0.150 |
Why?
|
Bacterial Adhesion | 1 | 2019 | 316 | 0.150 |
Why?
|
Polysaccharide-Lyases | 1 | 2017 | 48 | 0.150 |
Why?
|
Glucuronides | 1 | 2017 | 20 | 0.150 |
Why?
|
Long-Term Potentiation | 1 | 2019 | 293 | 0.150 |
Why?
|
Alkalies | 1 | 2017 | 52 | 0.150 |
Why?
|
Iatrogenic Disease | 1 | 2020 | 546 | 0.150 |
Why?
|
von Willebrand Factor | 1 | 2021 | 669 | 0.140 |
Why?
|
DNA-Binding Proteins | 1 | 2014 | 9648 | 0.140 |
Why?
|
Toll-Like Receptor 9 | 1 | 2018 | 211 | 0.140 |
Why?
|
Cecum | 1 | 2017 | 237 | 0.140 |
Why?
|
Editorial Policies | 1 | 2021 | 451 | 0.140 |
Why?
|
Ligation | 1 | 2017 | 452 | 0.140 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2019 | 552 | 0.140 |
Why?
|
N-Acetylglucosaminyltransferases | 1 | 2017 | 171 | 0.140 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2017 | 250 | 0.140 |
Why?
|
Sheep | 1 | 2018 | 1437 | 0.130 |
Why?
|
Punctures | 1 | 2017 | 374 | 0.130 |
Why?
|
Staphylococcus aureus | 2 | 2024 | 1453 | 0.130 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2006 | 1411 | 0.130 |
Why?
|
Membrane Proteins | 2 | 2024 | 7880 | 0.120 |
Why?
|
Trauma Severity Indices | 1 | 2016 | 481 | 0.120 |
Why?
|
Transcription Factors | 1 | 2014 | 12209 | 0.120 |
Why?
|
Enzyme Activation | 2 | 2012 | 3701 | 0.120 |
Why?
|
Aged | 9 | 2023 | 163178 | 0.120 |
Why?
|
Epithelial Cells | 2 | 2017 | 3690 | 0.120 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 808 | 0.110 |
Why?
|
Predictive Value of Tests | 2 | 2022 | 15067 | 0.110 |
Why?
|
Stroke | 1 | 2016 | 9975 | 0.110 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 2019 | 1121 | 0.110 |
Why?
|
Thoracostomy | 1 | 2013 | 72 | 0.110 |
Why?
|
Nicotine | 1 | 2017 | 681 | 0.110 |
Why?
|
Bacteria | 1 | 2023 | 2112 | 0.100 |
Why?
|
Chemokine CXCL1 | 1 | 2012 | 101 | 0.100 |
Why?
|
Caspase 3 | 1 | 2014 | 758 | 0.100 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2013 | 4422 | 0.100 |
Why?
|
Receptors, Tumor Necrosis Factor, Type I | 1 | 2012 | 264 | 0.100 |
Why?
|
Prognosis | 3 | 2022 | 29052 | 0.100 |
Why?
|
Microcirculation | 1 | 2016 | 1287 | 0.100 |
Why?
|
MicroRNAs | 2 | 2017 | 3750 | 0.100 |
Why?
|
Tobacco Smoke Pollution | 1 | 2017 | 816 | 0.100 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2019 | 1572 | 0.100 |
Why?
|
Anemia | 1 | 2020 | 1502 | 0.100 |
Why?
|
Pandemics | 2 | 2021 | 8385 | 0.090 |
Why?
|
Intestinal Perforation | 1 | 2012 | 253 | 0.090 |
Why?
|
Bacterial Proteins | 2 | 2024 | 3850 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2014 | 2503 | 0.090 |
Why?
|
Adoptive Transfer | 1 | 2012 | 844 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2012 | 620 | 0.080 |
Why?
|
1-Methyl-3-isobutylxanthine | 1 | 2008 | 102 | 0.080 |
Why?
|
Blood-Air Barrier | 1 | 2008 | 25 | 0.080 |
Why?
|
Female | 13 | 2022 | 380020 | 0.080 |
Why?
|
Gene Knockout Techniques | 1 | 2012 | 807 | 0.080 |
Why?
|
Surgical Flaps | 1 | 2017 | 1629 | 0.080 |
Why?
|
Erythrocytes | 1 | 2018 | 2455 | 0.080 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2012 | 1159 | 0.080 |
Why?
|
Burns | 1 | 2019 | 1815 | 0.080 |
Why?
|
Fibrosis | 1 | 2015 | 2030 | 0.080 |
Why?
|
Sex Factors | 1 | 2022 | 10394 | 0.080 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2008 | 211 | 0.080 |
Why?
|
Thrombosis | 1 | 2021 | 2968 | 0.080 |
Why?
|
Cyclic GMP | 1 | 2008 | 408 | 0.070 |
Why?
|
Extracellular Matrix | 1 | 2015 | 1743 | 0.070 |
Why?
|
Mice, Transgenic | 2 | 2022 | 9731 | 0.070 |
Why?
|
Graft Survival | 1 | 2017 | 3734 | 0.070 |
Why?
|
Adult | 8 | 2023 | 213889 | 0.070 |
Why?
|
Hypersensitivity | 1 | 2015 | 1102 | 0.070 |
Why?
|
Homeostasis | 1 | 2017 | 3337 | 0.070 |
Why?
|
Partial Pressure | 1 | 2006 | 254 | 0.070 |
Why?
|
Acute Disease | 1 | 2016 | 7150 | 0.070 |
Why?
|
Respiratory Muscles | 1 | 2006 | 139 | 0.060 |
Why?
|
Water | 1 | 2012 | 1394 | 0.060 |
Why?
|
Cyclic AMP | 1 | 2008 | 1472 | 0.060 |
Why?
|
Decorin | 1 | 2023 | 40 | 0.060 |
Why?
|
Aging | 1 | 2023 | 8655 | 0.060 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2004 | 188 | 0.060 |
Why?
|
Poly(ADP-ribose) Polymerases | 2 | 2017 | 437 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3308 | 0.060 |
Why?
|
Cathelicidins | 1 | 2023 | 80 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 5983 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2014 | 2914 | 0.060 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2916 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 19894 | 0.060 |
Why?
|
Leukocytes | 1 | 2012 | 2044 | 0.060 |
Why?
|
Trypsin | 1 | 2024 | 511 | 0.060 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7270 | 0.060 |
Why?
|
Phosphofructokinase-2 | 1 | 2022 | 32 | 0.060 |
Why?
|
NF-kappa B | 1 | 2012 | 2500 | 0.060 |
Why?
|
Disaccharides | 1 | 2023 | 171 | 0.060 |
Why?
|
Intensive Care Units | 1 | 2016 | 3679 | 0.050 |
Why?
|
Time Factors | 2 | 2022 | 40038 | 0.050 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2004 | 426 | 0.050 |
Why?
|
Middle Aged | 8 | 2021 | 213241 | 0.050 |
Why?
|
Blood Platelets | 1 | 2013 | 2509 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 56392 | 0.050 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2017 | 2428 | 0.050 |
Why?
|
Stem Cells | 1 | 2015 | 3566 | 0.050 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2023 | 362 | 0.050 |
Why?
|
Carbon Dioxide | 1 | 2006 | 1150 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9139 | 0.050 |
Why?
|
Cell Movement | 1 | 2013 | 5216 | 0.050 |
Why?
|
Partial Thromboplastin Time | 1 | 2021 | 206 | 0.050 |
Why?
|
Peptide Hydrolases | 1 | 2024 | 633 | 0.050 |
Why?
|
Adolescent | 3 | 2024 | 85729 | 0.050 |
Why?
|
Proteoglycans | 1 | 2023 | 837 | 0.050 |
Why?
|
Cricetulus | 1 | 2022 | 818 | 0.040 |
Why?
|
Prone Position | 1 | 2021 | 194 | 0.040 |
Why?
|
Fatal Outcome | 1 | 2004 | 1851 | 0.040 |
Why?
|
Rehydration Solutions | 1 | 2019 | 47 | 0.040 |
Why?
|
Nitric Oxide | 1 | 2008 | 2132 | 0.040 |
Why?
|
Biofilms | 1 | 2024 | 615 | 0.040 |
Why?
|
Immunity, Innate | 1 | 2011 | 2961 | 0.040 |
Why?
|
Extracellular Matrix Proteins | 1 | 2023 | 850 | 0.040 |
Why?
|
Thorax | 1 | 2022 | 547 | 0.040 |
Why?
|
CHO Cells | 1 | 2022 | 1409 | 0.040 |
Why?
|
Child | 2 | 2024 | 77637 | 0.040 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2022 | 627 | 0.040 |
Why?
|
Creatinine | 2 | 2015 | 1918 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 21733 | 0.040 |
Why?
|
Cricetinae | 1 | 2022 | 2475 | 0.040 |
Why?
|
Financing, Organized | 1 | 2019 | 202 | 0.040 |
Why?
|
Osteoclasts | 1 | 2022 | 729 | 0.040 |
Why?
|
RNA Transport | 1 | 2017 | 48 | 0.040 |
Why?
|
Matrix Metalloproteinases | 1 | 2020 | 391 | 0.040 |
Why?
|
Kidney Tubules | 1 | 2019 | 488 | 0.040 |
Why?
|
Lectins | 1 | 2019 | 513 | 0.040 |
Why?
|
Carbohydrate Conformation | 1 | 2017 | 209 | 0.040 |
Why?
|
Prospective Studies | 2 | 2023 | 53250 | 0.040 |
Why?
|
Disease Progression | 1 | 2013 | 13273 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2012 | 13028 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 9272 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2019 | 1105 | 0.030 |
Why?
|
Osteoblasts | 1 | 2022 | 1164 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2020 | 686 | 0.030 |
Why?
|
Fibrinogen | 1 | 2019 | 894 | 0.030 |
Why?
|
Fibronectins | 1 | 2019 | 726 | 0.030 |
Why?
|
Bronchi | 1 | 2019 | 840 | 0.030 |
Why?
|
Pulmonary Fibrosis | 1 | 2019 | 530 | 0.030 |
Why?
|
Protein Conformation | 1 | 2022 | 4009 | 0.030 |
Why?
|
Blood Urea Nitrogen | 1 | 2013 | 191 | 0.030 |
Why?
|
Catheterization | 1 | 2019 | 1469 | 0.030 |
Why?
|
Ovalbumin | 1 | 2015 | 719 | 0.030 |
Why?
|
Lipocalins | 1 | 2013 | 170 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 1656 | 0.030 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2020 | 1678 | 0.030 |
Why?
|
Random Allocation | 1 | 2017 | 2429 | 0.030 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2014 | 443 | 0.030 |
Why?
|
Acute-Phase Proteins | 1 | 2013 | 262 | 0.030 |
Why?
|
Protein Kinases | 1 | 2019 | 1640 | 0.030 |
Why?
|
Teaching | 1 | 2019 | 1173 | 0.030 |
Why?
|
Models, Molecular | 1 | 2022 | 5445 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2021 | 2159 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 975 | 0.020 |
Why?
|
Up-Regulation | 1 | 2020 | 4221 | 0.020 |
Why?
|
Immunization | 1 | 2015 | 1255 | 0.020 |
Why?
|
Peroxidase | 1 | 2013 | 611 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2021 | 2760 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2006 | 7908 | 0.020 |
Why?
|
Swine | 1 | 2019 | 5909 | 0.020 |
Why?
|
Oncogene Proteins | 1 | 2013 | 749 | 0.020 |
Why?
|
Retrospective Studies | 3 | 2023 | 77410 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1156 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2013 | 1200 | 0.020 |
Why?
|
Gene Deletion | 1 | 2015 | 2749 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2017 | 8300 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6380 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1898 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2013 | 2167 | 0.020 |
Why?
|
Cell Line | 1 | 2020 | 15993 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2023 | 7172 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2017 | 1911 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15526 | 0.020 |
Why?
|
Risk Factors | 2 | 2022 | 72252 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 2015 | 3794 | 0.010 |
Why?
|
Odds Ratio | 1 | 2017 | 9848 | 0.010 |
Why?
|
Crohn Disease | 1 | 2017 | 2304 | 0.010 |
Why?
|
Interleukin-6 | 1 | 2013 | 3208 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 57744 | 0.010 |
Why?
|
Cohort Studies | 1 | 2006 | 40545 | 0.010 |
Why?
|
Cognition | 1 | 2019 | 6759 | 0.010 |
Why?
|
Rats | 1 | 2017 | 24250 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 3047 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 25032 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2021 | 39001 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19232 | 0.010 |
Why?
|
Hospitalization | 1 | 2017 | 10259 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 13869 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2021 | 63042 | 0.010 |
Why?
|
United States | 1 | 2021 | 69859 | 0.010 |
Why?
|